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Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Korea 
Background/Aims: To determine whether female smokers are more or less susceptible to the detrimental pulmonary-
function effects of smoking when compared to male smokers among patients with lung cancer. 
Methods: Pack-years and pulmonary function indices were compared between 1,594 men and women with lung cancer 
who were smokers or had a history of smoking. Differences in individual susceptibility to smoking were estimated using a 
susceptibility index formula. 
Results: Of the patients, 959 (92.8%) men and 74 (7.2%) women were current smokers. Common histological types of 
lung cancer were squamous cell carcinoma, adenocarcinoma, and small cell carcinoma, among others. Women had a 
lower number of pack-years, forced expiratory volume in 1 second (FEV1, liters), forced vital capacity (FVC, liters), and total 
lung capacity (TLC, liters) compared to those of men (25.0 ± 19.2 vs. 42.9 ± 21.7 for pack-years; 1.4 ± 0.5 vs. 2.0 ± 0.6 for 
FEV1; 3.0 ± 0.7 vs. 2.0 ± 0.6 for FVC; 4.5 ± 0.8 vs. 5.7 ± 1.0 for TLC; all p < 0.001). The susceptibility index for women was 
significantly higher compared to that of men (1.1 ± 4.1 vs. 0.7 ± 1.1; p = 0.001). A significant inverse association was shown 
between the susceptibility index and TLC and FVC (r = -0.200 for TLC, -0.273 for FVC; all p < 0.001).
Conclusions: The results suggest that the detrimental effects of smoking on pulmonary function are greater in women, as 
compared to those in men, among patients with lung cancer.  
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INTRODUCTION 
Lung cancer and chronic obstructive pulmonary dis-
ease, which are two distinct phenotypes, are highly likely 
to be attributable to smoking. To date, these two diseases 
are understood as a single continuum or a different out-
come from the same insult [1]. The potential interaction of 
gender with the effects of smoking on the development of 
these diseases is a major clinical issue but one that is not 
well established. Pulmonary function is one of the most 
useful indicators for estimating the hazardous effects of 
smoking on the lungs [2]. 
Many studies had been conducted to verify whether the 
harmful effects of smoking on pulmonary function differ 
according to gender [3-12]. These studies were conducted 
on healthy populations or patients with chronic obstruc-
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tive pulmonary disease and showed inconsistent results. 
Although the effects of smoking on carcinogenesis be-
tween men and women have been reported with mixed 
results in cohort and case-control studies, the effect of 
smoking on pulmonary function in patients with lung can-
cer according to gender has not been examined [13-16].
Therefore, we conducted this study to investigate if 
susceptibility to smoking was different between men and 
women in a hospital-based lung cancer cohort. 
METHODS 
Patients and pulmonary function testing
Of approximately 2,300 patients with lung cancer who 
were diagnosed between 2001 and 2009 at the Lung Can-
cer Cohort of Inha University Hospital (Incheon, Korea) 
[17], all consecutive patients who were smokers or had a 
history of smoking and who took a pulmonary function 
test at diagnosis were initially considered for this study 
(Fig. 1). Information including body mass index, histologi-
cal type, and smoking habits was obtained from a data 
system. Patients with obstruction of the trachea or a lobar 
bronchus and significant pleural effusion were excluded, 
because these factors can potentially affect the results of 
pulmonary function testing. 
Pulmonary function testing was performed by a certi-
fied technician following the American Thoracic Society 
recommendations [18]. Forced expiratory volume in 1 
second (FEV1, liters or percentage), forced vital capacity 
(FVC, liters or percentage), and total lung capacity (TLC, 
liters or percentage) were estimated. Data on smoking 
habits were prospectively collected by a well trained re-
search nurse who interviewed patients and asked “Have 
you ever smoked?”, and “Do you smoke now?” Pack-years 
smoked were calculated by asking, “How many cigarettes 
do you smoke per day on average?” and “How long did you 
smoke?”   
Outcome 
We evaluated the susceptibility index (SI) to quantify 
the decrease in individual pulmonary function with a sus-
ceptibility index formula: [100 - % FEV1] / pack-years [9]. 
This formula assumes that each patient’s baseline FEV1 
would be normal (100% of predicted) without the hazard-
ous effects of smoking. The SI was defined as the loss of 
pulmonary function (measured in % predicted FEV1) per 
pack-year smoked. 
Statistical analysis
Differences in clinical variables between men and wom-
en were compared using the c
2 test for categorical variables 
and the independent t test for continuous variables. Cor-
relations between the SI and pulmonary function were 
evaluated with Pearson’s c
2 test. All statistical testing was 
performed at the two-sided 0.05 level. All analyses were 
performed using SAS version 9.1.3 (SAS Institute, Cary, 
NC, USA).
RESULTS
Patient characteristics
Table 1 shows the distribution of clinical characteris-
tics by gender in the 1,594 patients. Patients consisted of 
1,490 men (959 current-smokers, 526 former-smokers) 
and 104 women (74 current-smokers, 29 former-smokers). 
Ages ranged from 28 to 89 years (median, 67). Pack-years 
smoked in women were significantly lower than those of 
men (p < 0.001). No differences in body mass index or dis-
tribution of histological types or stage were found between 
men and women.
Pulmonary function and the SI
Women had significantly lower estimates of FEV1, FVC, 
and TLC compared to those of men (2.0 vs. 1.4, 3.0 vs. 2.0, 
5.7 vs. 4.5, respectively; all p < 0.001). The SI estimates 
2,289 Lung cancer patients
1,594 Smokers
Susceptibility index Pulmonary function indices
(100 - % predicted FEV1)
Pack-years smoked
Excluded
237 Never smokers
449 Pulmonary function testing, not available
       or obstruction or pleural effusion
    9 Smoking history, not available
=
FEV1
FVC
TLC
Figure 1. Patient enrollment. FEV1, forced expiratory volume in 
1 sec; FVC, forced vital capacity; TLC, total lung capacity.ryu JS, et al. Smoking susceptibility in lung cancers     429
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in women were significantly higher compared to those 
in men (1.1 vs. 0.7% per pack-years; p = 0.001) (Fig. 2). 
The SI estimate showed a significant inverse relationship 
with liters of FVC or TLC (r = -0.273, p < 0.001 for FVC; 
r = -0.200, p < 0.001 for TLC) (Fig. 3). The SI estimates 
also showed a significant relationship with FVC based on 
gender (r = -0.331, p < 0.001 for men; r = -0.380, p < 0.001 
for women) and TLC (r = -0.143, p = 0.002 for men; r =             
- 0.277, p = 0.053 for women, data not shown).
DISCUSSION
This study demonstrated, for the first time, that pul-
monary function in female patients with lung cancer may 
be more susceptible to the hazardous effects of smoking 
than that of men. The higher susceptibility of women, who 
showed a significantly lower amount of smoking compared 
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Figure 2. Susceptibility index for patients with lung cancer ac-
cording to gender.
Table 1. Characteristics of the 1,594 patients with lung cancer and their smoking habits
Variables
Men
(n = 1,490)
Women
(n = 104)
p value
Age, yr 65.4 (9.5) 68.5 (11.4) < 0.001
Body mass index, kg/m
2  22.0 (3.2) 22.1 (3.2) 0.800
Smoking habits Current  959 (92.8) 74 (7.2) 0.164
Former  526 (94.8) 29 (5.2)
Pack-years
< 40
≥ 40
42.9 (21.7) 25.0 (19.2) < 0.001
Histology Squamous cell carcinoma  741 (94.3) 45 (5.7) 0.375
Adenocarcinoma  387 (91.7) 35 (8.3)
Small cell carcinoma  232 (93.5) 16 (6.5)
Others  130 (94.2)   8 (5.8)
Stages I   247 (92.9) 19 (7.1) 0.383
II  126 (96.2)   5 (3.8)
III 542 (94.1) 34 (5.9)
IV 567 (92.5) 46 (5.9)
Limited    85 (93.4)   6 (6.6) 1.000
Extensive  147 (93.6) 10 (6.4)
Pulmonary function FEV1, L 2.0 (0.6) 1.4 (0.5) < 0.001
FEV1, % predicted 77.0 (22.1) 77.2 (20.1) 0.927
FVC, L 3.0 (0.7) 2.0 (0.6) < 0.001
FVC, % predicted 88.0 (20.6) 83.6 (19.9) 0.037
TLC, L 5.7 (1.0) 4.5 (0.8) < 0.001
TLC, % predicted 95.2 (16.6) 100.0 (16.9) 0.162
Values are presented as number (%).
FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity; TLC, total lung capacity.430    The Korean Journal of Internal Medicine Vol. 26, No. 4, December 2011
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to men, originated from their lower lung volume. 
It has been a controversial issue as to whether a gender 
difference is present regarding the detrimental effects of 
smoking on pulmonary function [3-12]. Our results were 
similar to some previous cross-sectional or longitudinally 
designed studies conducted in an otherwise healthy popu-
lation or in patients with chronic obstructive pulmonary 
disease [3,7-9]. However, to directly compare results 
of studies with different designs or subjects is a matter 
for concern because of epidemiological biases, such as a 
healthy smoking effect or a different prevalence of smok-
ers, originating from the heterogeneity of the population, 
and the existence of individual variation regarding the 
harmful effects of smoking on pulmonary function. Unlike 
previous series, this study was conducted among patients 
with lung cancer who came from a hospital-based cohort. 
All subjects in this study were expected to have lung can-
cer due to smoking and, thus, were likely to have homog-
enous characteristics in terms of the hazardous effects of 
smoking.
In this study, we used the SI to evaluate susceptibility. 
This index was originally designed to quantify a decrease 
in FEV1 as a result of pack-years smoked in patients with 
chronic obstructive pulmonary disease. Although women 
presented with significantly fewer pack-years, compared to 
those of men, the SI was significantly higher in women, as 
compared to that in men (0.7 vs. 1.1; p = 0.001). Dransfield 
et al. [9] reported that the SIs of men and women are 
0.9 and 1.1, respectively, for Caucasians and 1.2 and 1.4, 
respectively, for African-American patients with chronic 
obstructive pulmonary disease. Considering similar SI 
estimates and different amounts smoked between these 
Caucasian and African-American women (40-45 pack-
years) and Korean female patients with lung cancer (25 
pack-years) in this study, it could be postulated that an 
ethnic difference may have modulated the deleterious 
effects. Our results showed a significant inverse 
relationship between SI and FVC and TLC, indicating that 
higher susceptibility in women might be attributed to their 
lower lung volume. It could be postulated that the more 
harmful effects of smoking could be expected after a given 
amount smoked in patients with a smaller lung volume. 
The present study had some limitations. First, we did 
not collect detailed information on smoking habits such 
as brand name or depth of inhalation, which could affect 
pulmonary function [5]. Second, the number of female 
smokers with lung cancer in this study could be too small 
to compare variables by gender, given that the incidence 
of female smokers in South Korea is approximately 2%, 
which is much lower than that of other countries. Third, a 
serial estimate of the annual decline in pulmonary func-
tion is the most valuable method to assess the harmful 
effects of smoking. Alternatively, we estimated the effect 
using the SI, which assesses loss of pulmonary function 
per pack-years smoked. 
Nevertheless, our results suggest that female smokers 
with lung cancer are more susceptible to the hazardous ef-
fects of smoking, as compared to men. 
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Figure 3. Correlations between the susceptibility index and pulmonary function in patients with lung cancer.ryu JS, et al. Smoking susceptibility in lung cancers     431
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